These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2850147)

  • 21. Analysis of extrahepatic bile duct carcinomas according to the New American Joint Committee on Cancer staging system focused on tumor classification problems in 222 patients.
    Hong SM; Kim MJ; Pi DY; Jo D; Cho HJ; Yu E; Ro JY
    Cancer; 2005 Aug; 104(4):802-10. PubMed ID: 15959914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors for radical resection of middle and distal bile duct cancer.
    Nomura T; Tsuchiya Y; Nashimoto A; Yabusaki H; Takii Y; Nakagawa S; Sato N; Kanbayashi C; Tanaka O
    Hepatogastroenterology; 2009; 56(90):294-8. PubMed ID: 19579585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Carcinoma of the extrahepatic bile duct].
    Huang DR; Jin XL
    Zhonghua Zhong Liu Za Zhi; 1988 Jan; 10(1):67-9. PubMed ID: 3416703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of cancer of the gallbladder and bile duct].
    Koga A; Nakayama F
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1526-33. PubMed ID: 7184460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiotherapy and razoxane in advanced bile duct carcinomas.
    Rhomberg W; Stephan H; Böhler F; Erhart K; Eiter H
    Anticancer Res; 2005; 25(5):3613-8. PubMed ID: 16101189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of extrahepatic bile duct disease in infancy and early childhood.
    Steinau G; Krischer S; Staatz G; Marx A; Schumpelick V
    Technol Health Care; 2002; 10(1):33-7. PubMed ID: 11847446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns and relevant factors of tumor recurrence for extrahepatic bile duct carcinoma after radical resection.
    Park SW; Park YS; Chung JB; Kang JK; Kim KS; Choi JS; Lee WJ; Kim BR; Song SY
    Hepatogastroenterology; 2004; 51(60):1612-8. PubMed ID: 15532789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.
    Takada T; Amano H; Yasuda H; Nimura Y; Matsushiro T; Kato H; Nagakawa T; Nakayama T;
    Cancer; 2002 Oct; 95(8):1685-95. PubMed ID: 12365016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type.
    Adachi Y; Yasuda K; Inomata M; Sato K; Shiraishi N; Kitano S
    Cancer; 2000 Oct; 89(7):1418-24. PubMed ID: 11013353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carcinoma of the gallbladder and extrahepatic bile duct in autopsy cases of the aged, with special reference to its relationship to gallstones.
    Kimura W; Shimada H; Kuroda A; Morioka Y
    Am J Gastroenterol; 1989 Apr; 84(4):386-90. PubMed ID: 2929559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnostic and therapeutic strategy in carcinoma of the extrahepatic bile ducts].
    Paliard P; Marin-Laflèche JP; Chavaillon A; Bret PM; Bretagnolle M; Valette JP; Partensky C
    Gastroenterol Clin Biol; 1985; 9(8-9):617-21. PubMed ID: 3908207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The combination therapy of local administration of OK-432 and radiation for 2 cases of lower bile duct carcinoma].
    Mukai M; Morita S; Tsunemoto H
    Nihon Gan Chiryo Gakkai Shi; 1989 Mar; 24(3):617-21. PubMed ID: 2768973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carcinoma of the extrahepatic bile duct.
    Rezkalla MA; Luther J; Schafer L
    S D J Med; 1993 Sep; 46(9):333-6. PubMed ID: 8256134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Palliation of non-resectable carcinomas of the extrahepatic duct system.
    Pecora C; Khanna S; Gradone FP
    J Med Soc N J; 1977 Dec; 74(12):1063-5. PubMed ID: 73590
    [No Abstract]   [Full Text] [Related]  

  • 37. Endocrine cells in extrahepatic bile duct carcinoma.
    Yamamoto M; Takahashi I; Iwamoto T; Mandai K; Tahara E
    J Cancer Res Clin Oncol; 1984; 108(3):331-5. PubMed ID: 6150939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metastatic mucinous adenocarcinoma of the distal common bile duct, from transverse colon cancer presenting as obstructive jaundice.
    Lee DH; Ahn YJ; Shin R; Lee HW
    Korean J Hepatobiliary Pancreat Surg; 2015 Aug; 19(3):125-8. PubMed ID: 26379735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Jaundice in carcinoma breast--the need for revised outlook.
    Chaudhary A; Bose SM; Gupta MM
    Indian J Cancer; 1985 Sep; 22(3):189-93. PubMed ID: 2438203
    [No Abstract]   [Full Text] [Related]  

  • 40. [Obstructive jaundice and advanced gastric carcinoma--correlation with its histopathology].
    Saida Y; Tsunoda H; Kurosaki Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1989 Apr; 49(4):399-406. PubMed ID: 2798044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.